|
Volumn 6, Issue 1, 2002, Pages 57-68
|
Myasthenia gravis and Lambert-Eaton syndrome
|
Author keywords
Immunotherapy of neuromuscular disease; Lambert Eaton syndrome; Myasthenia gravis; Plasma exchange
|
Indexed keywords
AMBENONIUM;
AZATHIOPRINE;
CALCIUM CHANNEL P TYPE;
CALCIUM CHANNEL Q TYPE;
CHOLINERGIC RECEPTOR;
CHOLINESTERASE INHIBITOR;
CORTICOSTEROID;
CYCLOSPORIN A;
IMMUNOGLOBULIN;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NEOSTIGMINE;
PREDNISONE;
PYRIDOSTIGMINE;
ANOREXIA;
ARTICLE;
ASEPTIC NECROSIS;
AUTOIMMUNE DISEASE;
BONE MARROW SUPPRESSION;
CATARACT;
CLINICAL FEATURE;
DISEASE COURSE;
EATON LAMBERT SYNDROME;
ELECTRODIAGNOSIS;
HUMAN;
HYPERTENSION;
MUSCLE WEAKNESS;
MYASTHENIA GRAVIS;
NAUSEA;
OSTEOPOROSIS;
PLASMAPHERESIS;
PRIORITY JOURNAL;
THYMECTOMY;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
LAMBERT-EATON MYASTHENIC SYNDROME;
MYASTHENIA GRAVIS;
PLASMAPHERESIS;
|
EID: 0036120709
PISSN: 10916660
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1526-0968.2002.00403.x Document Type: Article |
Times cited : (11)
|
References (48)
|